Identical genetic changes in different histologic components of Wilms' tumors

Journal of the National Cancer Institute

Volumn 89, Issue 15, 1997, Pages 1148-1152

  Zhuang, Zhengping ^a,d   Merino, Maria J ^a   Vortmeyer, Alexander O ^a   Bryant, Bonita ^a   Lash, Alexander E ^a   Wang, Chaoyu ^a   Deavers, Michael T ^b   Shelton, Wilfred F ^b   Kapur, Sudesh ^c   Chandra, Roma S ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT;

ALLELE; ARTICLE; BLASTEMA; CANCER CYTODIAGNOSIS; CHILDHOOD CANCER; CHROMOSOME 11P; CLINICAL ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MARKER GENE; NEPHROBLASTOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030749642     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.15.1148     Document Type: Article

References (25)

1. Williamson KA, Van Heyningen V. Towards an understanding of Wilms' tumour. Int J Exp Pathol 1994;75:147-55.
2. Masson P. The role of neural crests in the embryonal adenosarcomas of the kidney. Am J Cancer 1938;33:1-32.
3. Grimes MM, Wolff M, Wolff JA, Jaretzki A 3d, Blanc WA. Ganglion cells in metastatic Wilms' tumor. Review of a histogenetic controversy. Am J Surg Pathol 1982;6:565-71.
4. Riccardi VM, Sujansky E, Smith AC, Francke U. Chromosomal imbalance in the Aniridia-Wilms' tumor association: 11p interstitial deletion. Pediatrics 1978;61:604-10.
5. Francke U, Holmes LB, Atkins L, Riccardi VM. Aniridia-Wilms' tumor association: evidence for specific deletion of 11p13. Cytogenet Cell Genet 1979;24:185-92.
6. Fearon ER, Vogelstein B, Feinberg AP. Somatic deletion and duplication of genes on chromosome 11 in Wilms' tumours. Nature 1984;309:176-8.
7. Koufos A, Hansen MF, Lampkin BC, Workman ML, Copeland NG, Jenkins NA, et al. Loss of alleles at loci on human chromosome 11 during genesis of Wilms' tumour. Nature 1984;309:170-2.
8. Orkin SH, Goldman DS, Sallan SE. Development of homozygosity for chromosome 11p markers in Wilms' tumour. Nature 1984;309: 172-4.
9. Reeve AE, Housiaux PJ, Gardner RJ, Chewings WE, Grindley RM, Millow LJ. Loss of a Harvey ras allele in sporadic Wilms' tumour. Nature 1984;309:174-6.
10. Lewis WH, Yeger H, Bonetta L, Chan HS, Kang J, Junien C, et al. Homozygous deletion of a DNA marker from chromosome 11p13 in sporadic Wilms' tumor. Genomics 1988;3:25-31.
11. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 1990;60:509-20.
12. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GA. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 1990;343: 774-8.
13. Zhuang Z, Bertheau P, Emmert-Buck M, Liotta LA, Gnarra J, Linehan WM, et al. A new microdissection technique for archival DNA analysis of specific cell populations in lesions less than 1 mm in size. Am J Pathol 1995;146: 620-5.
14. Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE. Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc Natl Acad Sci U S A 1991; 88:9618-22.
15. Bagasra O, Hauptman SP, Lischner HW, Sachs M, Pomerantz RJ. Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction. N Engl J Med 1992;326:1385-91.
16. Chen RH, Fuggle SV. In situ cDNA polymerase chain reaction. A novel technique for detecting mRNA expression. Am J Pathol 1993; 143:1527-34.
17. Man YG, Zhuang Z, Bratthauer G, Bagasra O, Tavassoli FA. A detailed in situ RT-PCR protocol for preserving morphology and confining PCR products in routinely processed paraffin sections. Cell Vision 1996;3:383-96.
18. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedure. J Histochem Cytochem 1981;29:557-80.
19. Mannens M, Slater RM, Heyting C, Bliek J, de Kraker J, Coad N, et al. Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours. Hum Genet 1988;81:41-8.
20. Reeve AE, Sih SA, Raizis AM, Feinberg AP. Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells. Mol Cell Biol 1989;9:1799-803.
21. Pritchard-Jones K, Fleming S. Cell types expressing the Wilms's tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis. Oncogene 1991;6:2211-20.
22. Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971;68:820-3.
23. Knudson AG Jr, Strong LC. Mutation and cancer: a model for Wilms' tumor of the kidney. J Natl Cancer Inst 1972;48:313-24.
24. Brown KW, Wilmore HP, Watson JE, Mott MG, Berry PJ, Maitland NJ. Low frequency of mutations in the WT1 coding region in Wilms' tumor. Genes Chrom Cancer 1993;8:74-9.
25. Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteous D, Gosden C, et al. The candidate Wilms' tumour gene is involved in genitourinary development. Nature 1990;346: 194-6.